PeterJPilieroMD

PubMed

• 8 citations
  Boosted Tipranavir versus Darunavir in Treatment-Experienced Patients
  Mabrouk Elgadi, Peter J. Piliero> ;Drugs in R&D. 2011 Dec 1
• 3 citations
  Susceptibility of HIV-1 to tipranavir and other antiretroviral agents in treatment-experienced patients: The UTILIZE Study.
  John D. Baxter, Laveeza Bhatti, Eoin Coakley, Jennifer Bartczak, Marita McDonough, Richard Vinisko, Peter J. Piliero> ;Current HIV Research. 2010 May 31
• 9 citations
  Pharmacokinetic Assessment of Nevirapine and Metabolites in Human Immunodeficiency Virus Type 1-Infected Patients with Hepatic Fibrosis
  Anna Maria Cammett, Thomas R. MacGregor, Jan M. Wruck, Franco Felizarta, Patrick Miailhes, Josep Mallolas, Peter J. Piliero> ;Antimicrobial Agents and Chemotherapy. 2009 Oct 1
• 50 citations
  Differential Effects of Tipranavir plus Ritonavir on Atorvastatin or Rosuvastatin Pharmacokinetics in Healthy Volunteers
  Paul A. Pham, C. J. L. la Porte, Lawrence S. Lee, R P G van Heeswijk, John P. Sabo, Mabrouk Elgadi, Peter J. Piliero, Patricia Barditch-Crovo, Edward J. Fuchs, Charles...> ;Antimicrobial Agents and Chemotherapy. 2009 Oct 1
• 18 citations
  Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
  R. Douglas Bruce, Frederick L. Altice, David E. Moody, Shen Nan Lin, Wenfang B. Fang, John P. Sabo, Jan M. Wruck, Peter J. Piliero, Carolyn Conner, Laurie Andrews, Ger...> ;Drug and Alcohol Dependence. 2009 Dec 1
• 18 citations
  Effect of ritonavir-boosted tipranavir or darunavir on the steady-state pharmacokinetics of elvitegravir.
  Anita Mathias, John Hinkle, Gong Shen, Jeff Enejosa, Peter J. Piliero, Vanitha Sekar, Rebecca Mack, Frank Tomaka, Brian P. Kearney> ;Journal of Acquired Immune Deficiency Syndromes. 2008 Oct 1
• 21 citations
  Efficacy And Safety of Three Doses of Tipranavir Boosted with Ritonavir in Treatment-Experienced HIV Type 1-Infected Patients
  Joseph Gathe, Gerald Pierone, Peter J. Piliero, Keikawus Arastéh, Rafael Rubio, Richard G. Lalonde, David A. Cooper, Adriano Lazzarin, Veronika Kohlbrenner, Catherine ...> ;AIDS Research and Human Retroviruses. 2007 Feb 27
• 5 citations
  Ritonavir-boosted protease inhibitors: impact of ritonavir on toxicities in treatment-experienced patients.
  Michael Sension, Peter J. Piliero> ;The Journal of the Association of Nurses in AIDS Care. 2007 Jan 1
• 5 citations
  Interaction between Fosamprenavir, with and without Ritonavir, and Nevirapine in Human Immunodeficiency Virus-Infected Subjects
  Edwin DeJesus, Peter J. Piliero, Kim Summers, Mary Beth Wire, Daniel S. Stein, Amanda Masterman, Yu Lou, Sherene S. Min, Mark J. Shelton> ;Antimicrobial Agents and Chemotherapy. 2006 Sep 1
• 7 citations
  Pharmacokinetics, pharmacodynamics and safety of once-daily versus twice-daily dosing with enfuvirtide in HIV-infected subjects.
  Melanie A. Thompson, Edwin DeJesus, Gary Richmond, David Wheeler, John P. Flaherty, Peter J. Piliero, Andrea True, Yu Yuan Chiu, Ying Zhang, Emily McFalls, G. Diego Mi...> ;AIDS. 2006 Feb 14
• 59 citations
  Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks.
  Benoit Trottier, Sharon Walmsley, Jacques Reynes, Peter J. Piliero, Mary O'Hearn, Mark T. Nelson, Julio S. G. Montaner, Adriano Lazzarin, Jacob Lalezari, Christine Kat...> ;Journal of Acquired Immune Deficiency Syndromes. 2005 Dec 1
• 131 citations
  Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 cli...
  Mark T. Nelson, Keikawus Arastéh, Bonaventura Clotet, David A. Cooper, Keith Henry, Christine Katlama, Jacob Lalezari, Adriano Lazzarin, Julio S. G. Montaner, Mary O'H...> ;Journal of Acquired Immune Deficiency Syndromes. 2005 Dec 1
• 90 citations
  Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults.
  Jacob Lalezari, Melanie Thompson, Priny Kumar, Peter J. Piliero, Richard J. Davey, Kristine B. Patterson, Anne Shachoy-Clark, Kimberly K. Adkison, James F. Demarest, Y...> ;AIDS. 2005 Sep 23
• 21 citations
  Appropriate Use of Nevirapinefor Long-Term Therapy
  Jonathan Leith, Peter J. Piliero, Stephen Storfer, Douglas L. Mayers, Ralf Hinzmann> ;The Journal of Infectious Diseases. 2005 Aug 1
• 5 citations
  Strategies for initiating combination antiretroviral therapy.
  Michael L. Tapper, Eric S. Daar, Peter J. Piliero, Kimberly Y. Smith, Corklin Steinhart> ;AIDS Patient Care and Stds. 2005 Apr 25
• 8 citations
  Atazanavir: A novel once-daily protease inhibitor.
  Peter J. Piliero> ;Drugs of Today. 2004 Nov 1
• 44 citations
  Atazanavir—A Once-daily HIV Protease Inhibitor That Does Not Cause Dyslipidemia in Newly Treated Patients: Results from Two Randomized Clinical Trials
  Pedro Cahn, José M. Gatell, Kathleen Squires, Lisa Percival, Peter J. Piliero, Ian A. Sanne, Sarah Shelton, Adriano Lazzarin, Linda Odeshoo, Thomas Kelleher, Alexandra...> ;Journal of the International Association of Physicians in AIDS Care. 2004 Jul 1
• Developments in HIV treatments: strategies for success.
  Peter J. Piliero> ;The AIDS Reader. 2004 Dec 1
• 66 citations
  Pharmacokinetic properties of nucleoside/nucleotide reverse transcriptase inhibitors.
  Peter J. Piliero> ;Journal of Acquired Immune Deficiency Syndromes. 2004 Sep 1
• Buffalo hump: what the experts suggest.
  Peter J. Piliero, Grace A. McComsey> ;AIDS Clinical Care. 2004 Mar 1
• 27 citations
  Pharmacokinetics and safety of GW433908 and ritonavir, with and without efavirenz, in healthy volunteers.
  Mary Beth Wire, Charles Ballow, Sandra L. Preston, Craig W. Hendrix, Peter J. Piliero, Yu Lou, Daniel S. Stein> ;AIDS. 2004 Apr 9
• 12 citations
  Diaphragmatic paralysis due to isolated phrenic neuropathy in an HIV-infected man.
  Peter J. Piliero, Lydia Estanislao, David M. Simpson> ;Neurology. 2004 Jan 13
• 3 citations
  Pharmacodynamics and clinical use of anti-HIV drugs.
  Sandra L. Preston, Peter J. Piliero, George L. Drusano> ;Infectious Disease Clinics of North America. 2003 Sep 1
• 23 citations
  Use of ultrasonography-assisted liposuction for the treatment of human immunodeficiency virus-associated enlargement of the dorsocervical fat pad.
  Peter J. Piliero, M. Hubbard, J. King, J. J. Faragon> ;Clinical Infectious Diseases. 2003 Nov 15
• 18 citations
  Drug interactions associated with HAART: focus on treatments for addiction and recreational drugs.
  John J. Faragon, Peter J. Piliero> ;The AIDS Reader. 2003 Sep 1
• Join now to see all